HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 51.00
Day range
zł 49.85 - zł 51.50
Year range
zł 47.00 - zł 72.40
Market cap
1.15B PLN
Avg Volume
3.92K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 17.71M | -48.85% |
Operating expense | 37.06M | 27.70% |
Net income | -27.75M | -225.56% |
Net profit margin | -156.74 | -536.38% |
Earnings per share | — | — |
EBITDA | -22.61M | -1,356.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 233.67M | 128.10% |
Total assets | 403.20M | -15.11% |
Total liabilities | 143.61M | 9.14% |
Total equity | 259.59M | — |
Shares outstanding | 23.12M | — |
Price to book | 4.54 | — |
Return on assets | -14.42% | — |
Return on capital | -21.45% | — |
Cash Flow
Net change in cash
(PLN) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -27.75M | -225.56% |
Cash from operations | -19.48M | -130.13% |
Cash from investing | 2.12M | 146.02% |
Cash from financing | -367.00K | 52.34% |
Net change in cash | -21.72M | -137.12% |
Free cash flow | 7.86M | 103.67% |
About
Founded
2007
Website
Employees
270